F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
Register & Login
Suven Pharmaceuticals Limited, a prominent player in the Contract Development and Manufacturing Organization (CDMO) sector, has demonstrated robust financial performance in recent quarters. This analysis delves into the company's current stock details and provides projected share price targets from 2025 to 2030, based on insights from reputable financial sources.
In this short but interesting blog, we will reveal Suven Pharmaceuticals Limited share price targets from 2025 to 2030 and analyze their current financial metrics, the market, and trends, as well as unbiased estimates by experts.
Current Stock Details of Suven Pharmaceuticals Limited
As of February 8, 2025, the latest available data from Moneycontrol.com provides the following stock details for Suven Pharmaceuticals Limited:
- Open: 1,150.00
- Current Share Price: ₹1,233.70
- Volume: 10,04,381
- Market Capitalization: 31.44KCr
- 52-Week High: 1,360.00
- 52-Week Low: 598.00
Suven Pharmaceuticals Share Price Target Forecasts (2025 to 2030)
Based on analyses from financial experts and market trends, here are the projected share price targets for Suven Pharmaceuticals Limited:
| Year | Projected Share Price (₹) |
|---|---|
| 2025 | ₹1,500.00 |
| 2026 | ₹1,750.00 |
| 2027 | ₹2,000.00 |
| 2028 | ₹2,250.00 |
| 2029 | ₹2,500.00 |
| 2030 | ₹2,750.00 |
Sources: Economic Times, Moneycontrol
Analysis of Suven Pharmaceuticals Share Price Targets
Suven Pharmaceuticals Limited Share Price Target 2025
Growth Factors:
- Expansion in the CDMO segment, with increased demand from global pharmaceutical companies.
- Successful advancement of molecules to Phase 3 clinical trials, enhancing the company's portfolio.
Suven Pharmaceuticals Limited Share Price Target 2026
Key Drivers:
- Onboarding of strategic global pharmaceutical partners, leading to a diversified client base.
- Continued revenue growth, driven by strong performance in core business segments.
Suven Pharmaceuticals Limited Share Price Target 2027
Growth Factors:
- Expansion into new markets and regions, increasing the company's global footprint.
- Investment in research and development, leading to innovative solutions and services.
Suven Pharmaceuticals Limited Share Price Target 2028
Key Factors:
- Strategic acquisitions and mergers, enhancing the company's capabilities and market position.
- Adoption of advanced technologies, improving operational efficiency and service offerings.
Suven Pharmaceuticals Limited Share Price Target 2029
Growth Drivers:
- Sustained growth in the pharmaceutical industry, with increasing demand for CDMO services.
- Strengthening of the company's financial position, with improved profit margins and revenue streams.
Suven Pharmaceuticals Limited Share Price Target 2030
Key Growth Factors:
- Leadership in the CDMO sector, with a reputation for quality and reliability.
- Continuous innovation and adaptation to industry trends, ensuring long-term sustainability.
Factors Influencing Suven Pharmaceuticals' Share Price Growth
-
Financial Performance: Strong quarterly results, with significant increases in net profit and revenue.
-
Strategic Partnerships: Collaboration with leading global pharmaceutical companies, expanding the client base.
-
Research and Development: Investment in advancing molecules to later stages of clinical trials, enhancing the product pipeline.
-
Market Expansion: Entry into new geographical markets, increasing the company's reach and revenue potential.
-
Technological Advancements: Adoption of cutting-edge technologies, improving operational efficiency and service quality.
FAQs on Suven Pharmaceuticals Share Price Target
Q1: What is the share price target for Suven Pharmaceuticals in 2025?
A1: The projected share price target for 2025 is ₹1,500.00.
Q2: What is the share price target for 2030?
A2: The anticipated share price target for 2030 is ₹2,750.00.
Q3: What are the primary growth drivers for Suven Pharmaceuticals' stock?
A3: Key drivers include expansion in the CDMO segment, strategic global partnerships, and continuous investment in research and development.
Q4: Is Suven Pharmaceuticals a good long-term investment?
A4: Given its strong financial performance, strategic initiatives, and market position, Suven Pharmaceuticals presents a promising long-term investment opportunity.
Conclusion
Suven Pharmaceuticals Limited is poised for significant growth in the coming years. The projected share price targets from 2025 to 2030 reflect a positive outlook, driven by strategic expansions, innovation, and market diversification. Investors are encouraged to monitor the company's developments and market trends to make informed decisions.
